Compounded product quality issues (suspected contamination, wrong labeling, broken cold chain) should be reported to the partner compounding pharmacy and to the FDA MedWatch program
Adults with a BMI of 30 or higher generally qualify for semaglutide therapy, while individuals with a BMI between 27 and 29.9 who also have weight-related health conditions such as high blood pressure, type 2 diabetes, or cardiovascular disease may also be candidates
For example, adding 1 mL or 2 mL to the same vial will create different concentrations
Starting at a low dose allows for the minimization of negative side effects
In the meantime, we had developed semaglutide I was there myself, so it was very interesting which was obviously a better compound than liraglutide, given weekly